Abstract
Heparin treatment can cause an immune-mediated thrombocytopenia: HIT. HIT antibodies can be detected by various methods, but laboratory analyses are not specific or sensitive and may delay the diagnostic process. It is therefore important to initiate alternative treatment based on the clinical findings, and a clinical score system for evaluating the risk of HIT has been suggested. When HIT is likely, treatment consists of immediate replacement of heparin with alternative anticoagulation treatment and refrainment from warfarin therapy and platelet infusion.
| Bidragets oversatte titel | Heparin-induced thrombocytopenia |
|---|---|
| Originalsprog | Dansk |
| Tidsskrift | Ugeskrift for Laeger |
| Vol/bind | 171 |
| Udgave nummer | 8 |
| Sider (fra-til) | 612-5 |
| Antal sider | 4 |
| ISSN | 0041-5782 |
| Status | Udgivet - 16 feb. 2009 |
| Udgivet eksternt | Ja |
Emneord
- Anticoagulants/adverse effects
- Arginine/analogs & derivatives
- Chondroitin Sulfates/therapeutic use
- Dermatan Sulfate/therapeutic use
- Fibrinolytic Agents/adverse effects
- Heparin/adverse effects
- Heparitin Sulfate/therapeutic use
- Hirudins
- Humans
- Pipecolic Acids/therapeutic use
- Recombinant Proteins/therapeutic use
- Risk Factors
- Sulfonamides
- Thrombocytopenia/chemically induced